Biotech

Peregrine Pharmaceuticals (NASDAQ:PPHM) shares were down 7.55% at the start of the week to $0.370 and an additional 5.46% in after-hours trading to $0.350. The company has a market cap of $111.15 million at 242.38 million shares outstanding. Share prices have been trading in a 52-week range of $0.29...

Price T Rowe is on a buying spree right now, and has today reported a host of transactions, with a primary focus on the biotech space. Spark Therapeutics was a major benefactor from the spree - here are the details. In a just published Form 13, filed with the US...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Prothena Corp Plc (NASDAQ:PRTA) reported that Price T Rowe Associates Inc has just bought a total of 3,514,610 of Prothena's common stock, with the filing dated 2016-12-12. The acquisition brings the total number of Prothena shares owned...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Microbot Medical Inc. (NASDAQ:MBOT) reported that Bornstein Yoseph has picked up 5,305,409 of common stock as of 2016-12-08. The acquisition brings the aggregate amount owned by Bornstein Yoseph to a total of 5,305,409 representing a...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Reata Pharmaceuticals Inc (RETA) (NASDAQ:RETA) reported that Huff James Warren has picked up 930,068 of common stock as of 2016-12-07. The acquisition brings the aggregate amount owned by Huff James Warren to a total of...